During the past decade, National Institute of Cancer conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Cancer" #1 collaborator was "Clinical Research Technology S.r.l." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Institute of Cancer" are "Melanoma" (1 trials) and "Metastatic Melanoma" (1 trials). Many other conditions were trialed in "National Institute of Cancer" in a lesser frequency.

Most popular intervention types in "National Institute of Cancer" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ipilimumab" (1 trials), "LGX818" (1 trials), "MEK162" (1 trials), "Nivolumab" (1 trials) and "Trametinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Cancer" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Institute of Cancer". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in National Institute of Cancer, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Cancer, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

National Institute of Cancer has several departments that took part in Clinical trials: "Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale" - 4 trials